Goldmann L, Duan R, Kragh T, et al. Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT? Blood Adv. 2019;3(23):4021-4033.. Blood Adv 2020; 4 (1): 112. doi: https://doi.org/10.1182/bloodadvances.2019001362
Download citation file:
The generic names of some drugs were omitted from the original supplemental data. The error has been corrected in the online data supplement.
Sign In or Create an Account